tiprankstipranks
Ideaya Biosciences appoints Stu Dorman as chief commercial officer
PremiumThe FlyIdeaya Biosciences appoints Stu Dorman as chief commercial officer
1M ago
Ideaya Biosciences nominates IDE034 as development candidate, exercises option
Premium
The Fly
Ideaya Biosciences nominates IDE034 as development candidate, exercises option
1M ago
Biocytogen announces Ideaya’s nomination of development candidate IDE034
Premium
The Fly
Biocytogen announces Ideaya’s nomination of development candidate IDE034
1M ago
Ideaya Biosciences reports Q3 EPS (60c), consensus (63c)
PremiumThe FlyIdeaya Biosciences reports Q3 EPS (60c), consensus (63c)
2M ago
Ideaya Biosciences announces IND clearance for Werner Helicase inhibitor
Premium
The Fly
Ideaya Biosciences announces IND clearance for Werner Helicase inhibitor
2M ago
Ideaya Biosciences announces IDE397 expansion data
Premium
The Fly
Ideaya Biosciences announces IDE397 expansion data
2M ago
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
PremiumThe FlyIdeaya Biosciences announces inducement grants under Nasdaq listing rule
3M ago
Ideaya Biosciences price target lowered to $52 from $54 at Wedbush
Premium
The Fly
Ideaya Biosciences price target lowered to $52 from $54 at Wedbush
3M ago
Ideaya Biosciences should be bought on weakness, says Citi
Premium
The Fly
Ideaya Biosciences should be bought on weakness, says Citi
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100